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Introduction 
 
It is widely recognised that Scotland has competitive advantage in key areas of science and technology 
within its research and company base. However, the nation performs relatively poorly in terms of numbers 
of active entrepreneurs, business start-ups and creation of high-growth technology businesses within 
knowledge intensive industries. Scotland needs to rapidly commercialise those technologies where there is 
both a strong market opportunity and an ambition to create or grow a company of scale. The Scottish 
Government’s Economic Strategy (Scottish Government, 2011) highlights the role that commercialisation 
can play in contributing to economic growth and Scottish Enterprise (SE) has built a clear strategic 
commitment to commercialisation: developing and investing in a number of initiatives and programmes to 
support the conversion of science and technology based ideas into products or services which deliver 
value to a particular market. 
 
With the ambition of converting the country’s wealth of research assets into economic assets, a better 
understanding of the mechanics and transitions by which technology based ideas are transformed into 
marketable goods and services across the ‘concept to commercialisation’ paradigm is key to improving 
success rates and economic benefits for Scotland. This paper sets out the key findings from primary 
research that gives a unique insight into the experience of 32 companies that have been supported by SE. 
The research evidence highlights the challenges involved in the commercialisation process and path to 
market for Scottish-based technology companies, whose origins may be existing technology businesses, 
university spin-outs or start-up companies, and is the first in-depth analysis of its kind in Scotland. 
 
Commercialisation and economic growth 
 
Policy makers have long recognised the contribution of commercialisation (defined as the conversion of 
ideas into successful commercial ventures) to economic growth and productivity improvement. Where 
technological innovation (most commonly comprising incremental change within existing industries) is 
critical to long-term economic growth, transformational economic growth can occur only with the 
introduction of truly new goods and services, i.e. radical technological innovations that disrupt markets and 
create new industries. 
 
Few relationships are more broadly supported by both theory and empirical evidence than successfully 
exploited technological innovation and sustained economic growth; and yet until around 20 years ago 
economists focussed little on the process by which ideas are transformed into new products and services, 
or how new industries and sectors of economic activity are formed and develop. 
 
While the process through which a scientific or technological idea with potential commercial value is 
successfully converted into marketable products and/or services is highly complex (a complexity catalysed 
more recently by rapid advances across scientific frontiers), understanding the concept-to- 
commercialisation transition is essential in the formulation of both business strategy and public policy. 
 
“You can have the best technology in the world, but for successful commercial implementation 
the essential focus has to be delivering innovative, on-time and cost effective solutions the market 
requires” 
- Des Gibson, Chairman & CEO, Gas Sensing Solutions 
(The Royal Society of Scotland: Science Scotland. Issue 12 Spring 2012) 
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Looking at the nation’s assets, from a technology perspective Scotland’s research base has a good track 
record of producing outputs with global recognition. The Royal Society of Edinburgh (2012), however, 
highlight that Scotland has a less convincing record of ‘commercialising these at the speed and scale 
necessary to translate them into internationally compelling propositions’. 
 
The commercialisation process 
 
As part of the aim to improve Scotland’s commercialisation performance, SE undertook a strategic review 
of its commercialisation activity spanning the period 2004-2008 (SE, 2009). A follow-up review (via face-to- 
face interviews with 32 SE supported beneficiary companies over the period 2008 to 2011) was published 
in 2012 (SE, 2012) and identified a number of key findings in establishing critical success factors in the 
journey to successful commercialisation, including: 
 
 the need to build strong commercially focussed management and leadership teams who 
can establish route to market early in the process and who show ambition to sell in to 
international markets; 
 the  importance  of  an  outward  looking  perspective  and  the  need  to  build  strong 
competitive positions by establishing new connections and building relationships with 
universities, customers, competitors, as well as via widening supplier relationships; and 
 the importance of access to finance when time to product launch is increasingly critical 
but where companies are taking longer to get to market and at greater cost; though 
successful companies are getting better at attracting new sources of finance and support 
from outside Scotland. 
 
The  research  exercise  adopted  the  ‘Branscomb  Model’   (see  Figure  1)  as   the  framework   for 
conceptualising the company ‘journey’, allowing a mapping of company development from ‘basic research’ 
through to a ‘growing business’ across four key stages (Branscomb and Auerswald, 2002). While it is 
recognised that this framework represents an idealised view of technology progression (i.e. in reality the 
journey is often neither a linear process nor easily phased), the model includes multiple parallel streams 
and iterative loops making the approach a readily understood concept with which to engage businesses. 
 
 
 
The characteristics of the survey sample, according to technology development stage and trading position 
at the time of interview, are summarised in Table 1 below: 
 
Table 1: Company characteristics 
 
Company 
Characteristics 
  Branscomb Stage  
Sample size 32   Proving the Concept 3% 
Origin 44% spin outs   Technology Development 22% 
Status 91% limited company   Product Development 22% 
Sector 44% enabling 
technology* 
41% life sciences 
  Production/Marketing 31% 
 
Trading status 34% pre-revenue  Growing Business 22% 
 
* defined as technologies that can be applied across more than one sector, such as electronics, high-value manufacturing, advanced 
materials, digital technologies, photonics and sensors, etc. 
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In an attempt to better understand this complex and important area of government policy, the remainder of 
this paper draws on the research study findings and outlines the key enablers and blockers to successful 
commercialisation, considers policy implications and identifies future research activity. 
 
As the recession and anaemic recovery has taken its toll businesses are taking longer to get to 
market, are finding time to product launch becoming more critical and that it is costing more, 
though they are getting better at attracting new sources of finance and support from outside 
Scotland 
 
Development time to get to market is lengthening 
 
A common difficulty cited by companies across each of the development stages was ‘time to completion’, 
with the evidence suggesting it is now taking an average of 5 years (60 months) to get to market from the 
initial ‘proving of concept’, 4-5 months longer than the sample of companies were reporting pre-recession. 
These findings mirror the company experience across other economies, with the time taken for a company 
to go from initial investment to IPO lengthening around the world since 2000, correlating strongly with 
conditions in the wider macro economy: the average time to flotation during the highs of the dotcom boom 
was around 3 years before increasing to 5-6 years in the aftermath of the dot com crash and lengthening 
further to historic average highs of 7+ years (NESTA, 2010). 
 
From a sectoral perspective, as would be expected, companies in the 'enabling technology’ field were 
slightly quicker through all commercialisation stages than those in ‘life sciences’, due to the less human- 
focussed element and the need for regulatory approval. This is similar to findings of other research studies 
(Nesta, 2010). When disaggregating the results by business origin, spin-outs indicated a shorter ‘product 
development’ stage (9 months vs 13 months across the sample), possibly due to the amount of early-stage 
development that occurs within a spin-out prior to company launch. 
 
Current challenges facing companies affecting stage length are, in order of importance: 
 
 difficulty  in  raising  finance  (which  is  having  a  negative  effect  on  cash  flow,  and, 
therefore,   product/service   development   timescales,   and   while   equity   finance   is 
accessible it is taking time to negotiate); 
 commercial skills gaps (specifically during ‘product development’ and 
‘production/marketing’ stages which acts to slow down products getting to market and in 
some cases resulting in staggered product launch); 
 technical uncertainty (increasing duration of the ‘product development’ stage); 
 technology skills gaps (increasing duration of early stage ‘technology development’ and 
‘product development’ stages); 
 sales cycles taking longer than anticipated (mainly via establishing the sales process 
and setting up distribution channels); 
 regulatory approval taking longer than anticipated; and 
 difficulty in finding partners/collaborators to support product development. 
 
And as a result it is costing more 
 
An increase in stage length is negatively affecting a number of companies who are either running out of 
money or having to spend more time than the pre-recession sample sourcing investment to the detriment 
of other business priorities. It is encouraging, however, to note that the companies appear to be raising the 
finance required (even if they are working harder for it and it is taking longer to source) suggesting well 
developed investor-ready propositions. 
 
From an absolute perspective, companies are needing more money to get to market and are funding this 
in various ways: median costs are indicated to have risen by around 20% to £920,000 since the financial 
crisis, though it is acknowledged this finding is influenced by the mix of sectors supported (the sample 
contains a number of life science companies and spin-outs that have the potential to achieve a scale of 
impact but which require higher development costs). 
 
Disaggregating the proportion of expenditure by the respective development stages highlights clear peaks 
at the ‘product development’ and ‘growing business’ stages: at 6%, 16%, 34%, 7%, 37%. Sitting behind 
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these averages is clear industry variation, e.g. technology development costs for software businesses is 
close to nil versus around 13% for the bio-pharmaceutical industry. 
 
In terms of use of funding, typically around 60% of expenditure goes to labour input vs 40% for 
development and running costs. Comparing to studies undertaken in other geographies (Booz Allen 
Hamilton, 2003; Auerswald et al, 2005), the proportion of expenditure at ‘product development’ by these 
Scottish companies is a significantly lower proportion, indicating a better balance across the stages and a 
likely ability to use resources more efficiently, a valuable skill in today’s business environment. The 
downside to this, however, is the ‘drip-feed’ nature of early-stage funding for potential high-growth 
businesses means they often find themselves in the resource consuming process of actively seeking the 
next capital injection which is to the detriment of the development of the business itself. 
 
With companies funding finance requirements in a variety of ways with public sector support remaining 
crucial and with sources beyond Scotland being accessed 
 
A wealth of research highlights the complexity and scale of the financial architecture required to support 
the journey to commercialisation, particularly those engaging in novel applications that are inherently risky 
ventures for potential investors (see for example Technology Strategy Board, 2011). As a result of the 
changing financial climate, and the associated increased costs involved in securing funding, companies 
are using a different mix of investment and sources of finance to develop and grow. 
 
In terms of scale, early-stage technology companies often require large up-front capital injections with 
regular follow-on tranches of investment. On account of holding intangible assets rather than tangible 
collateral, and with a likely lengthy lead time to revenue generation, finance is typically hard to obtain from 
conventional debt financing sources. 
 
The champions of early-stage technology projects identified as part of this research are making use of a 
wide variety of funding options such as angel networks and venture capital finance. Further, as funding 
tightens across the domestic public sector, successful companies are seeking support beyond Scotland to 
UK and European sources, via for example the Technology Strategy Board (TSB), the Department for 
Business, Innovation and Skills (BIS), the Department for Energy and Climate Change (DECC), the 
National Institute for Health (NIH) and the NHS in order to help fill funding gaps. 
 
The importance of public sector investment (which acts to provide direct support and help create the 
necessary conditions to attract private investment) can be seen in the mix of funding available such as co- 
investment with private funds (both venture capital and angel financing) and the uptake of ‘bridging’ 
funding vehicles to facilitate external private investments in early-stage businesses. Other research has 
highlighted that whereas public funds hardly featured during the dotcom era, they now they participate in 
around 40% of all venture capital deals and 55% of all early-stage deals (NESTA, 2010). 
 
Figure 2 sets out the mix of investment and finance sources used to grow and develop the SE supported 
businesses, disaggregating total financial contribution by source and distribution of spend according to 
Branscomb stage and with the majority of spend denoted within the shaded areas. From this it is clear 
that: 
 
 private (equity) sector investment – contributed around 45% across the stages. At any point 
45%-70%  of  businesses  are  using  this  type  of  funding,  peaking  at  the  ‘product 
development’ stage 
 more life sciences than enabling technologies  companies  accessed private 
investment, possibly explained by the higher development costs associated 
with life science activity 
 spin-out   companies   accessed   less   private   finance   at   early-stages   of 
development than non-spin outs, but on reaching ‘production/marketing’ this 
situation reversed, possibly because of the earlier support within a university 
environment and comparatively low running costs when located within a 
university; 
 
 public sector support contributed around 30% of total funding requirements with the majority 
of monies accessed at an early stage. While often unmatched by private sector funding 
during the ‘proving the concept’ stage, by early stage ‘technology development’ public sector 
funding  becomes  100%  match  funded  (60%  by  the  private  sector  and  40%  with 
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company/own  money).  Around  90%  of  businesses  access  public  sector  funding  by the 
‘technology development’ stage; 
 
 the  proportion  of  company  own  finance  reinvested  in  the  business,  at  close  to  25%, 
increases  as  companies  move  towards  the  ‘growing  business’  stage  as  they  begin 
generating sales, undertaking contract work and generating income from licenses; 
 
 companies  are  funding  future  plans  from  their  own  cash  at  the  early  stages  of  the 
development journey, used by around 60% of businesses during the ‘proving the concept 
stage’, which falls to around 1 in 8 of businesses by the ‘growing business’ stage; 
 
 no companies in the sample accessed bank funding with many having been turned down for 
general bank finance. 
 
Despite the increased cost requirements highlighted earlier, the effects of the financial climate and the 
resulting changing focus of risk capital markets, the key message from this research is that in spite of the 
difficulty experienced in raising funding and the resource-intensive nature of doing so, SE supported 
businesses are developing sufficiently attractive investor-ready propositions and that funding requirements 
are being met. 
 
Figure 2: disaggregation of overall financial contribution to project funding 
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Award range (min to max): 
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Companies are building strong management and leadership teams, focussing on their human 
capital in order to address key skills gaps and identifying route(s)-to-market early in the process 
 
The research highlighted a series of inter-connected critical success factors that include: 
 
 management  team  experience:  requiring  individuals  with  a  track  record  of  product 
development, planning for success and successful execution of commercialisation plans 
in order to plot a course through the development process and anticipate potential 
hurdles on the journey to market; 
 human capital & capability: ensuring that the right stock of knowledge exists across the 
business to enable it to participate effectively in the marketplace; 
 market focus as opposed to technology focus: focusing on route(s)-to-market from early- 
stage ‘technology development’ and the ability to execute early sales which gives both 
credibility to the company and confidence to the sales team. 
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The role of effective leadership 
 
Developing investor-ready propositions at the earliest stage is a key component in the development of a 
successful technology business, where chances of success are closely correlated to the commercial 
experience of the management team. An increased commercial focus  ensures  the ability to build a 
stronger competitive position by identifying company priorities, assessing capabilities, defining potential 
performance gaps and determining investment requirements at the earliest stage. The ability to recognise 
the importance of identifying route-to-market and the value of export markets from the outset ensures 
positioning of the business to overcome the hurdles to be faced and sets it on the course towards 
successful product/service exploitation. 
 
Expansion of leadership teams and/or teams with improved capability is a key theme, with the sample of 
companies clearly focussing on management team capability at an early stage (80% of management 
teams have a track record of starting businesses and 40% of businesses are committed to formal training 
to  strengthen  skills  and  fill  gaps,  such  as  understanding  of  intellectual  property,  marketing,  market 
research and sales). 
 
University spin-outs were more likely to undertake management training (around 95%) compared to start- 
ups (around 75%). A higher proportion of spin-outs also sought support to build their management team 
(circa 40% compared to circa 25%). This greater need for training and support in spin-outs businesses 
allies with the perception that the majority of senior management teams originate from a non-commercial 
background. The high level of training is evidence of progressive, learning organisations that understand 
this need and are acting to create sustainable businesses. 
 
Stock of human capital 
 
Human capital reflects a large part of the stock of knowledge and capability within a business (defined as 
the knowledge, skills, behaviours and commitment of employees), and is a key input to innovation, where 
skill levels are often used as a measure of the quality of labour input. Acting as one dimension of a firm’s 
intangible assets, these elements are key differentiators in building the organisational capability that 
supports execution of the commercialisation plan (Robinson and Sexton, 1994). The Technology Strategy 
Board (2010) asserts that a diverse range of skills ‘from market analysis to technology development, and 
from intellectual property management to business modelling’ are required, but that it is inherently difficult 
for businesses developing disruptive technologies to appoint an experienced workforce with these 
associated skills. 
 
Across the development stages, the research identified a number of key themes: 
 
 skills  barriers  peaked  during  ‘production/marketing’  with  60%  of  companies  citing 
barriers/shortages,  with  barriers  also  at  the  ‘product  development’  and  ‘growing 
business’ stages acting as a brake and contributing to increased stage length; 
 technology skills gaps are evident during early stage ‘technology development’ and the 
‘product development' stage, while sales and marketing skills gaps are also recognised 
throughout  the  development  process,  peaking  at  the  ‘product  development’  and 
‘production/marketing’ stages and again acting to slow the time it takes for products to 
get to market; 
 the use of private sector consultants to fill skills gaps across all stages is used widely, 
peaking at 45% of businesses at the ‘production marketing’ stage and 40% during the 
‘growing business’ stage. 
Examples of specific skills gaps cited include: 
 sufficiently experienced and skilled design engineers or lead scientists (affecting all 
development stages); 
 engineering graduates with industry/practical experience; 
 graduates with good technical skills; and 
 sales, marketing and business development skills (cited from early in the development 
cycle, often as early as ‘technology development’). 
 
In the short term, as businesses progress to develop a portfolio of products/services, gaps may remain 
through companies having insufficient finance to recruit the right calibre of individual full-time or being 
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unable to source personnel within the product development timescales. The expansion of business and 
technical networks, and specifically the increased links with universities, has the potential to minimise such 
gaps. Further, in the medium-to-longer term, businesses stated that they expected commercial skills gaps 
to narrow. 
 
Early market focus 
 
There  is  clear evidence  from  the  research that companies  are  focusing on  understanding  preferred 
route(s)-to-market at an early stage in company development. Developing a clear route to market is 
essential for the commercialisation of any new product/service and is identified as a key element in the 
ecosystem for successful businesses, whether the most complex and expensive ‘develop, manufacture, 
sell’ option or lower-cost, lower-risk licensing agreements or distribution partnerships. It is a complicated, 
resource intensive process to set up and get right requiring an understanding of the hurdles to be 
overcome, such as barriers to entry and growth opportunities in target markets, patenting costs, regulatory 
compliance and national/regional procurement regulations. Selling a product directly to the market requires 
appropriate skills in branding, design and marketing, while selling in overseas markets requires additional 
patent protection as well as an understanding of export and distribution costs. 
 
A high proportion of companies surveyed cited engagement with Scottish Development International (SDI) 
from an early stage. This aligns with the idea of an earlier market focus, and in particular export market 
development, where companies were using SDI for trade missions, exploring the market and helping 
develop future distribution channels. 
 
An increased focus on accessing overseas markets highlights improved strategic thinking. The benefits of 
exporting to a wide range of markets (commonly) include a greater probability of survival and financial 
performance, as well as enabling companies to specialise in areas of relative strength, become more 
efficient, increase productivity, increase innovation intensity and reduce market risk by diversifying their 
customer base. During the ‘growing business’ phase 80% of businesses reported export sales as a key 
objective, to be achieved via joint venture or distribution arrangements and with over 80% of revenues 
projected to be generated by export sales by 2016. 
 
Companies are building strong competitive positions and are outward looking in their perspective 
 
As the mechanics of innovation and commercialisation become better understood, it is clear they rarely 
occur in isolation but rather reflect a highly interactive and multidisciplinary practice undertaken by a 
growing a diverse network of actors (OECD, 2010). 
 
Access to complementary sources of knowledge acquisition act to offset elements of uncertainty and/or 
lack of in-house capability while catalysing the potential to create radically new products/services (Marvel, 
2012). The research reveals that the SE supported companies are outward looking and building a strong 
competitive position at an early stage in the development process. 
 
Successful commercialisation often requires the ability to co-operate effectively with other key actors, 
whether informal in nature (via networks) or through formal contracting. Actors include both the private 
sector (with companies as suppliers, customers, competitors and consultants) and the public sector 
(incorporating universities, government research institutions, funding agencies, etc). 
 
Wider evidence highlights that as the complexity and costs of technology driven innovation increase, more 
businesses are using partnerships to help to reduce lead times and increase market responsiveness. More 
businesses are also now collaborating in areas of non-technical innovation in order to expand the pool of 
innovative ideas they have access to and widen the scope of expertise on their innovation projects. 
 
The research highlights a group of companies who recognise the importance of collaboration and open 
innovation with other businesses, universities and support providers. Key highlights from the research 
include: 
 
 a high proportion of companies working with universities across development stages, for example 
circa 75% during the ‘proving the concept’ and early stage ‘Technology Development’ stages; and 
 recognition that where companies faced difficulty in making connection with customers until late 
in the development process this often resulted in costly and time consuming product re- 
engineering. 
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Lessons for policy support 
 
As discussed, a number of significant barriers to successful execution of business plans have emerged 
from the research exercise, a number of which have a distinct policy focus. Public sector assistance 
(particularly from SE) is viewed by all the supported companies as contributing to successful development 
suggesting future, targeted policy intervention is not only valid but welcome. Building on SE’s approach to 
commercialisation, further policy development activity has focussed in the following areas: lack of finance 
(specifically ways to try and address the gap of getting significant - £1m plus -investment into companies) 
and acceleration of project timing, where targeted responses include: 
 
 trialling the potential use of new powers for Young Innovative Enterprises (offering aid of 
up to €1m to small enterprises less than six years old) to develop products/services/ 
processes which are technologically new and carry a risk of technological or industrial 
failure; 
 active engagement with SDI in promoting opportunities with non-Scottish investors; and 
 activity  by  the  Scottish  Investment  Bank  to  engage  with  investors  based  outside 
Scotland; 
 
Other areas SE are exploring to improve future commercialisation outcomes include: 
 
 promoting entrepreneurialism; and 
 providing a more joined-up approach to SE’s product support offering to help make the 
transition from pre-company formation support to company specific support more fluid 
and seamless and to enable this transition to happen at the optimal time point. 
 
 
Conclusions 
 
This research suggests that line-of-sight to market, time to product launch, access to finance and cost 
control, strength and depth of management and leadership teams, connectivity across the innovation 
system and both access to, and utilisation of, human capital are key factors faced by Scottish technology 
companies in the development of intellectual property, the transition to successful commercialisation of 
resulting new or improved products/services and in the execution of ambitious growth plans. These 
elements are all barriers an economic development agency can assist businesses to overcome. To this 
end, and in order to continue to develop a more complete understanding of this complex area, a 
programme of future research is planned centred around the longitudinal tracking of the company journey 
with the aim of complementing the growing evidence base from which to develop policy based practice. 
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